About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITING

Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.

NCT04931537•Second Affiliated Hospital, School of Medicine, Zhejiang University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Diabetic Nephropathy Type 2Biomarker

Locations

1

China

Locations (1)

the Second Affiliated Hospital Zhejiang University Schoolof Medicine

Hangzhou, China

Key Dates

Start Date

May 1, 2021

Primary Completion Date

December 31, 2023

Completion Date

December 31, 2028

Last Updated

July 20, 2021

Related Studies

Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)

NCT07486401

Asthma ExacerbationsBiomarkers / Blood+1 more

Inflammatory Biomarkers and Postoperative Delirium in Pediatric Circumcision

NCT07323485

Postoperative DeliriumPediatric Anesthesia+1 more

Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers

NCT07071649

Alzheimer's DiseaseBiomarkers+2 more

RECRUITINGPhase 3

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

NCT07234695

Down SyndromeDown Syndrome (DS)+8 more

EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE

NCT07253701

EpilepsyMicrobiota+3 more

How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes

NCT06817252

PrediabetesLipid Profile+8 more

View all related studies

Contacts

Zheng Chao, MD, PhD

CONTACT

8615057585907 wallbb_1022@163.com

Sponsors

Lead Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

Second Affiliated Hospital of Wenzhou Medical University
Lishui Country People's Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2021Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions